Results 261 to 270 of about 9,166,726 (386)

Prevalence of Anterior Segment Diseases on a Remote Island: A Telemedicine-Based Study Using the Smart Eye Camera. [PDF]

open access: yesCureus
Kuroiwa R   +6 more
europepmc   +1 more source

Comparison of the Quantitative Myasthenia Gravis and Myasthenia Gravis Activity of Daily Living Scores From a Clinical Practice Perspective

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Myasthenia gravis (MG) is characterized by fluctuating symptoms, making the assessment of disease activity challenging. Discordance between the clinician‐reported quantitative myasthenia gravis (QMG) score and the patient‐reported MG activity of daily living (MG‐ADL) has previously been observed.
Wanqing Wu   +3 more
wiley   +1 more source

Smartphone video-based early diagnosis of blepharospasm using dual cross-attention modeling enhanced by facial pose estimation. [PDF]

open access: yesNPJ Digit Med
Huang S   +10 more
europepmc   +1 more source

The 10% Rule in Sentinel Node Biopsy: Is Removal of All Threshold Nodes Necessary?

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Sentinel lymph node biopsy (SLNB) procedures have been guided by the “10% rule,” which stipulates that any lymph node (LN) with gamma probe activity (GPA) measured at 10% of the most radioactive sentinel lymph nodes (SLNs) should be excised.
Jake Langlie   +5 more
wiley   +1 more source

Patient Perspectives of Quality Compared to Quantity of Life Regarding Orbital Exenteration

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Orbital exenteration (OE) impacts patients cosmetically, functionally, and psychosocially. Eye‐sparing strategies with the advent of immunotherapy have developed the potential to avoid OE but may result in suboptimal oncologic outcomes and reduced survival.
Kalpesh Hathi   +3 more
wiley   +1 more source

A new digital biomarker of Demodex blepharitis: energy curve of the meibomian edge. [PDF]

open access: yesFront Cell Dev Biol
Wang M   +6 more
europepmc   +1 more source

Efficacy and Toxicity of Inotuzumab Ozogamicin for Treatment of Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients After CD19‐Chimeric Antigen Receptor T‐Cell Therapy

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT We retrospectively analyzed outcomes for nine children and young adults who were treated with inotuzumab ozogamicin (InO) for relapsed/refractory (R/R) B‐acute lymphoblastic leukemia (ALL) after CD19‐chimeric antigen receptor T‐cell therapy (CART).
Paula Ogrodnik   +3 more
wiley   +1 more source

Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eleonora Minacapilli   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy